Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
5-fluorouracil vs Latanoprost with Microneedling for Vitiligo
NCT05513924Phase 3Completed
- Sponsor
- South Valley University
- Start
- Mar 2022
- Primary completion
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of fluorouracil 5% cream and latanoprost ophthalmic solution 0.005% (TearClear TC-002) in Vitiligo (2 arms), sponsored by South Valley University. Primary endpoint: Physician's Global Assessment at 6 months. Started Mar 2022; status: completed.
02
Drugs
fluorouracil 5% creamlatanoprost ophthalmic solution 0.005% (TearClear TC-002)
03
Conditions
Vitiligo
Beyond the preview
Go deeper on NCT05513924.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05513924.